Life Sciences Tools and Services
Company Overview of Nordion Inc.
Nordion Inc., a health science company, provides various products and services for the prevention, diagnosis, and treatment of diseases worldwide. The company operates in two segments, Sterilization Technologies and Medical Isotopes. The Sterilization Technologies segment offers Cobalt-60, a radioactive metal that emits radiation and sterilizes items by destroying contaminating micro-organisms; and dosimetry and professional services, as well as designs, constructs, and maintains commercial gamma sterilization systems. The Medical Isotopes segment provides various products that are used in the diagnosis and treatment of diseases, including cardiac and neurological conditions, and various typ...
447 March Road
Ottawa, ON K2K 1X8
Founded in 1946
Key Executives for Nordion Inc.
Chief Executive Officer, President, Non Independent Director and Member of Technology Committee
Chief Financial Officer and Senior Vice President
Senior Vice President, General Counsel and Corporate Secretary
Senior Vice-President of Corporate Services
Chief Operating Officer of Specialty Isotopes and General Manager of Sterilization Technologies
Compensation as of Fiscal Year 2015.
Nordion Inc. Key Developments
Dixons MVNO iD Taps Billing Platform from Tech Mahindra and MDS
May 14 15
Tech Mahindra and MDS have signed a strategic global agreement and signed Dixons Carphone's new MVNO, iD, as their first joint client. Tech Mahindra has implemented MDS' billing and customer management solution and will manage the entire services infrastructure for Dixons Carphone iD, which will operate over the 3 UK network.
MDS Appoints Russell Hunt as New Chief Financial Officer
Apr 23 15
MDS announced that Russell Hunt has joined the company as CFO. He will be providing financial leadership and expertise to support aggressive growth plans.
Sterigenics International and Nordion Announce Landmark Canada-U.S. Partnership Agreement to Provide a Long-Term, Reliable Supply of Medical Isotopes
Feb 20 15
Sterigenics International LLC and Nordion announced agreements with General Atomics and the University of Missouri Research Reactor Center to establish a new, reliable supply of medical isotopes that will serve millions of patients around the world. Nordion's current supply of Mo-99 is from the National Research Universal reactor at Chalk River, Ontario, operated by Canadian Nuclear Laboratories. The NRU is scheduled to cease routine production of Mo-99 in November 2016. However the Government of Canada announced recently that it will support the extension of the NRU operations until March 31, 2018 to help support global medical isotope demand in the unexpected circumstances of shortages during this time. This new medical isotope supply will be produced using General Atomics' innovative Selective Gaseous Extraction technology. The targets used will incorporate Low Enriched Uranium, in line with Nordion's commitment to the U.S. National Nuclear Security Administration's Global Threat Reduction Initiative.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries